Clinical Trials

Adenocarcinoma, Carcinoma, Neoplasm Metastasis, Neoplasms

NCT06128343 2026-03-19

BACAP-2

1,500 enrolled

Adenocarcinoma, Carcinoma, Neoplasms

NCT06505122 2026-03-19

DLR RCT

60 enrolled

Neoplasms

NCT07398677 2026-03-19

SchoolCare

128 enrolled

Phase NA Not yet recruiting

Neoplasms

NCT07481890 2026-03-19

Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients.

46 enrolled

Neoplasms

NCT02243592 2026-03-18

Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment

Active not recruiting

170 enrolled

Neoplasms

NCT02501174 2026-03-18

CONSOG

Completed

2,914 enrolled

Neoplasms

NCT04443088 2026-03-18

KEYNOTE-E12

78 enrolled

Neoplasm Metastasis, Neoplasms

NCT05719558 2026-03-18

A Study of ASP1002 in Adults for Treatment of Solid Tumors

210 enrolled

Neoplasm Metastasis, Neoplasms

NCT06298357 2026-03-18

Virtual Reality Gaming for Exercise and Mindfulness Among Pediatric Cancer Rehabilitation

Phase 1 Completed

11 enrolled

Neoplasms

NCT06658405 2026-03-18

HPV2

Phase 2 Recruiting

85 enrolled

Neoplasms

NCT07202507 2026-03-18

SNOOZE

20 enrolled

Neoplasms

NCT07226180 2026-03-18

Development and Application of Patient-Derived Models of Cancer

Enrolling by invitation

40 enrolled

Phase 1 Active not recruiting

Neoplasms

NCT04958239 2026-03-17

A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer

151 enrolled

Neoplasms

NCT07201038 2026-03-17

UF-WGS

50 enrolled

Phase 2/3 Not yet recruiting

Neoplasms

NCT07476443 2026-03-17

VitC-CoQ10

75 enrolled

Neoplasms

NCT00420563 2026-03-16

PAL-ANGI

Phase 2 Completed

88 enrolled

Neoplasms

NCT01374620 2026-03-16

PAL-ANGI2

Phase 1 Completed

28 enrolled

Neoplasms

NCT01415258 2026-03-16

VULNERABILITE

Completed

209 enrolled

Neoplasms

NCT02439047 2026-03-16

MESO-PATCH

Phase NA Terminated

6 enrolled

Neoplasms

NCT05371756 2026-03-16

TIOB

10,000 enrolled

Neoplasms

NCT05887882 2026-03-16

PNOC028

24 enrolled

Neoplasms

NCT06072833 2026-03-16

Characterizing and Addressing Financial Toxicity in AYAs With Cancer

Phase NA Completed

26 enrolled 8 charts

Neoplasms

NCT06150157 2026-03-16

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

220 enrolled

Neoplasms

NCT06730204 2026-03-16

Standardized Nutritional Management of Pediatric Patients With Solid Tumors

400 enrolled

Neoplasms

NCT06997029 2026-03-16

A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

234 enrolled

Neoplasms

NCT07030712 2026-03-16

MK-8294-001

67 enrolled

Phase 1 Active not recruiting

Neoplasm Metastasis, Neoplasms

NCT07474168 2026-03-16

T Cell Receptor Gene-Engineered and Dominant Negative TGF-β Receptor T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor

9 enrolled

Neoplasms

NCT00580515 2026-03-13

Trial of Family Focused Grief Therapy in Palliative Care and Bereavement

Phase NA Completed

700 enrolled

Neoplasms

NCT05862285 2026-03-13

UmbrellaMAX

Phase 3 Recruiting

100 enrolled

Neoplasms

NCT05909202 2026-03-13

A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients

218 enrolled

Neoplasms

NCT06178614 2026-03-13

A Study of JNJ-87890387 for Advanced Solid Tumors

200 enrolled

Neoplasms

NCT06941272 2026-03-13

MK-9999-01C

Phase 1/2 Recruiting

50 enrolled

Phase 1 Not yet recruiting

Neoplasms

NCT07454031 2026-03-13

Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma

22 enrolled

Neoplasm Metastasis, Neoplasms

NCT07471425 2026-03-13

TOLERATE

Not yet recruiting

1,100 enrolled

Neoplasms

NCT07471958 2026-03-13

eREACH3

360 enrolled

Neoplasms

NCT00923065 2026-03-12

Data Collection, Clinical Care and Interventions in CCR, NCI

Enrolling by invitation

10,000 enrolled

Phase 1/2 Active not recruiting

Neoplasms

NCT02908906 2026-03-12

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers

413 enrolled

Neoplasms

NCT04442425 2026-03-12

Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor Pain

Completed

83 enrolled

Phase NA Active not recruiting

Neoplasms

NCT04803604 2026-03-12

CASCADE

256 enrolled

Neoplasms

NCT06445140 2026-03-12

MONAGE

55 enrolled

Neoplasms

NCT06959810 2026-03-12

OEUVRE

55 enrolled

Neoplasms

NCT07468422 2026-03-12

OPTin

Active not recruiting

200 enrolled

Neoplasms

NCT00001163 2026-03-11

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer

Active not recruiting

5,201 enrolled

Neoplasms

NCT04609072 2026-03-11

Connect for Cancer Prevention Study (Connect)

200,000 enrolled

Neoplasms

NCT05714995 2026-03-11

HYPNO-AROMA

66 enrolled

Phase NA Active not recruiting

Neoplasms

NCT05763797 2026-03-11

Developing a Culturally Relevant Supportive Care Program for Black Patients Dealing With Advanced Cancer

170 enrolled

Phase 2 Active not recruiting

Neoplasms

NCT05993299 2026-03-11

Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

7 enrolled 15 charts

Phase NA Active not recruiting

Neoplasms

NCT06864260 2026-03-11

PREEMpT

300 enrolled